Julie Brahmer, MD, MSc
Johns Hopkins Medicine
Julie Brahmer, MD, MSc is a board-certified medical oncology physician and a Professor of Oncology in the Department of Oncology, Upper Aerodigestive Cancer, and Director of the Thoracic Oncology Program at Johns Hopkins University Medicine in Baltimore, Maryland.
She also serves as Co-Director of the Upper Aerodigestive Department at the Bloomberg–Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University. A leader in lung cancer, mesothelioma, and immunology, Dr Brahmer serves in multiple leadership roles including member of the Scientific Executive Committee at the National Lung Cancer Partnership/Free to Breathe, Chair of the Scientific Executive Committee at the National Lung Cancer Partnership, member of the Board of Directors at International Association for the Study of Lung Cancer, member of the Scientific Leadership Committee at Cancer Research Institute-Canadian Cancer Trials Group, and member of the Thoracic and Prevention Steering Committees at Eastern Cooperative Oncology Group. She serves on the Medical Advisory Boards of the Lung Cancer Research Fund and the Mesothelioma Applied Research Foundation and serves on the Medical and Scientific Advisory Boards of LUNGevity, the Lung Cancer Foundation of America, and the Lung Cancer Research Foundation. For her leadership, Dr Brahmer received the LUNGevity Hero Award from the LUNGevity Foundation in 2016.
She has authored or coauthored at least 160 peer-reviewed journal articles and has edited at least 1 book. Dr Brahmer’s clinical research focus includes development of anti-programmed cell death protein-1 antibodies and drug development for thoracic malignancies and immunotherapy.